Tevard Biosciences Appoints Dr. Gregory Robinson As Chief Scientific Officer

Nov 13, 2023•over 1 year ago

Company

Tevard Biosciences

CambridgeBiotechnologyHealth Care

Description

Tevard Biosciences, Inc., the pioneer of tRNA-based therapies and other mRNA-modulating treatments for genetic diseases, announced today that it has appointed Dr. Gregory Robinson as Chief Scientific Officer.

Company Information

Company

Tevard Biosciences

Location

Cambridge, Massachusetts, United States

About

Tevard Biosciences is pioneering tRNA-based and other mRNA-modulating therapies to cure a broad range of genetic diseases. The privately held biotechnology company was founded by MIT Professor and Whitehead Institute Founding Member Harvey Lodish, with life science entrepreneurs and executives Daniel Fischer and Warren Lammert, fathers of children with rare genetic diseases, and scientific co-founder Jeff Coller, a Bloomberg Distinguished Professor in the Department of Molecular Biology and Genetics at the Johns Hopkins University School of Medicine. Tevard is advancing the use of its novel Suppressor tRNA, Enhancer tRNA, and mRNA Amplifier platforms in neurological disorders, heart disease, and muscular dystrophies.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months